Shenzhen New Industries Biomedical Strategic Asset Allocation Index
Shenzhen New Industries Biomedical strategic asset allocation index. Shenzhen New Industries Biomedical (300832) has a Strategic Asset Allocation Index of 20.2% as of June 2023. Strategic assets (PP&E of CN¥1.34 Billion plus long-term investments of CN¥-) total CN¥1.34 Billion, measured against net assets of CN¥6.65 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300832 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shenzhen New Industries Biomedical (2016–2021)
Strategic asset allocation index of Shenzhen New Industries Biomedical from 2016 to 2021. This chart shows how Shenzhen New Industries Biomedical's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2023, the index stands at 20.2%, representing strategic assets of CN¥1.34 Billion against net assets of CN¥6.65 Billion CNY. Check 300832 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Shenzhen New Industries Biomedical Strategic Asset Allocation Index by Year (2016–2021)
Shenzhen New Industries Biomedical strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen New Industries Biomedical from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Shenzhen New Industries Biomedical.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 20.2% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥5.61 Billion | ▲ +3.5 pp |
| 2020 | 16.7% | CN¥803.51 Million | CN¥803.51 Million | CN¥- | CN¥4.80 Billion | ▼ -1.4 pp |
| 2019 | 18.1% | CN¥568.87 Million | CN¥568.87 Million | CN¥- | CN¥3.14 Billion | ▼ -8.2 pp |
| 2018 | 26.3% | CN¥622.54 Million | CN¥622.54 Million | CN¥- | CN¥2.37 Billion | ▼ -2.2 pp |
| 2017 | 28.6% | CN¥506.03 Million | CN¥506.03 Million | CN¥- | CN¥1.77 Billion | ▲ +6.2 pp |
| 2016 | 22.3% | CN¥317.02 Million | CN¥317.02 Million | CN¥- | CN¥1.42 Billion | — |